The National Medical Commission (NMC) has released the official NEET UG 2026 syllabus, outlining the topics to be covered in ...
Hematologists and oncologists from UC San Francisco shared research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology at the American Society of ...
Background PD-1 blockade has emerged as a promising approach for functional cure of chronic hepatitis B (CHB). Objective This study aimed to evaluate the safety profile of anti-PD-1 antibody (αPD-1), ...
The state Department of Education will develop guidelines for all 600 public school districts to limit the student use of ...
The centerpiece of the Trump administration’s revamp of the U.S. Navy is the largest surface combatant America will build ...
Learn more about whether Legend Biotech Corporation or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
The cellular therapy landscape continues to evolve beyond hematologic malignancies, now making significant progress in solid ...
Single-ascending dose portion of study has successfully completed 2.5 and 7 mg / kg levelsDose dependent immunosuppressive ...
Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi ® (tafasitamab) in combination with rituximab and lenalidomide for adult ...
A six-pack of notes and thoughts after UM’s riveting 10-3 playoff win at Texas A&M, as the Canes now advance to play Ohio ...
The waveLINE-003 trial demonstrates the efficacy of zilovertamab vedotin combined with standard therapy, with manageable safety profiles in difficult-to-treat DLBCL patients. ADCs provide logistical ...
Q4 2025 showcased the industry’s pivot toward precise biology, localised delivery, and earlier intervention – with multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback